Transient lentiviral vector production using a packed-bed bioreactor system
Date
2019
Authors
McCarron, A.
Donnelley, M.
McIntyre, C.
Parsons, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Human Gene Therapy, 2019; 30(3):93-101
Statement of Responsibility
Alexandra McCarron, Martin Donnelley, Chantelle McIntyre, and David Parsons
Conference Name
Abstract
Scalable lentiviral vector (LV) manufacturing is vital for successful commercialization of LV-based gene and cell therapy products. Accordingly, efforts are currently focused on developing and adapting technologies to address both upstream and downstream production bottlenecks. To overcome the limitations of current upstream processes, researchers are now favoring the use of bioreactors over traditional two-dimensional culture platforms. Bioreactors provide many advantages for manufacturing biomolecules, including process automation, tight regulation of production conditions, reduced labor input, and higher productivity potential. This study describes a transient LV production strategy employing a single-use, packed-bed bioreactor vessel. Functional LV titers in the 10⁶ TU/mL range were achieved, and after concentration yields of up to 10⁹ TU/mL were attained. This proof of principle study demonstrates that LV can be successfully produced in a packed-bed system. With further optimization, a packed-bed bioreactor could offer a potential scale-out solution for LV manufacturing.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2019 by Mary Ann Liebert, Inc.